Combined gene essentiality scoring improves the prediction of cancer dependency maps

Munoz, 2016, CRISPR screens provide a comprehensive assessment of cancer vulnerabilities but generate false-positive hits for highly amplified genomic regions, Cancer Discov, 6, 900, 10.1158/2159-8290.CD-16-0178 Fellmann, 2017, Cornerstones of CRISPR-Cas in drug discovery and therapy, Nat Rev Drug Discov, 16, 89, 10.1038/nrd.2016.238 Mullenders, 2009, Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer, Oncogene, 28, 4409, 10.1038/onc.2009.295 Morgens, 2016, Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes, Nat Biotechnol, 34, 634, 10.1038/nbt.3567 Doench, 2018, Am i ready for CRISPR? a user's guide to genetic screens, Nat Rev Genet, 19, 67, 10.1038/nrg.2017.97 Boettcher, 2015, Choosing the right tool for the job: RNAi, TALEN, or CRISPR, Mol Cell, 58, 575, 10.1016/j.molcel.2015.04.028 Barrangou, 2015, Advances in CRISPR-Cas9 genome engineering: lessons learned from rna interference, Nucleic Acids Res, 43, 3407, 10.1093/nar/gkv226 Doench, 2016, Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9, Nat Biotechnol, 34, 184, 10.1038/nbt.3437 de Weck, 2018, Correction of copy number induced false positives in CRISPR screens, PLoS Comput Biol, 14, 10.1371/journal.pcbi.1006279 Jaiswal, 2017, Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells, Genome Med, 9, 51, 10.1186/s13073-017-0440-2 Meyers, 2017, Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells, Nat Genet, 49, 1779, 10.1038/ng.3984 Aguirre, 2016, Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting, Cancer Discov, 6, 914, 10.1158/2159-8290.CD-16-0154 Ihry, 2018, p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells, Nat Med, 24, 939, 10.1038/s41591-018-0050-6 Haapaniemi, 2018, CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response, Nat Med, 24, 927, 10.1038/s41591-018-0049-z Tsherniak, 2017, Defining a cancer dependency map, Cell, 170, 10.1016/j.cell.2017.06.010 Peretz, 2018, Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism, Sci Rep, 8, 93, 10.1038/s41598-017-18551-z McFarland, 2018, Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration, Nat Commun, 9, 4610, 10.1038/s41467-018-06916-5 Smith, 2017, Evaluation of RNAi and crispr technologies by large-scale gene expression profiling in the connectivity map, PLoS Biol, 15, 10.1371/journal.pbio.2003213 Evers, 2016, CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes, Nat Biotechnol, 34, 631, 10.1038/nbt.3536 Hart, 2015, High-Resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities, Cell, 163, 1515, 10.1016/j.cell.2015.11.015 Wang, 2017, Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic ras, Cell, 168, 10.1016/j.cell.2017.01.013 Steinhart, 2017, Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors, Nat. Med., 23, 60, 10.1038/nm.4219 Hart, 2016, BAGEL: a computational framework for identifying essential genes from pooled library screens, BMC Bioinf, 17, 164, 10.1186/s12859-016-1015-8 Barretina, 2012, The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, 483, 603, 10.1038/nature11003 Golub, 2013 Eisenberg, 2013, Human housekeeping genes, revisited, Trends Genet TIG, 29, 569, 10.1016/j.tig.2013.05.010 Bailey, 2018, Comprehensive characterization of cancer driver genes and mutations, Cell, 173, 10.1016/j.cell.2018.02.060 Hart, 2014, Measuring error rates in genomic perturbation screens: gold standards for human functional genomics, Mol Syst Biol, 10, 733, 10.15252/msb.20145216 Robin, 2011, pROC: an open-source package for R and S+ to analyze and compare ROC curves, BMC Bioinf, 12, 10.1186/1471-2105-12-77 Vo, 2019, The landscape of circular RNA in cancer, Cell, 176, 10.1016/j.cell.2018.12.021 Maji, 2019, A high-throughput platform to identify small-molecule inhibitors of CRISPR-Cas9, Cell, 177, 10.1016/j.cell.2019.04.009 El-Brolosy, 2019, Genetic compensation triggered by mutant mRNA degradation, Nature, 568, 193, 10.1038/s41586-019-1064-z Zhang, 2011, Illustration of SSMD, z score, SSMD*, z* score, and t statistic for hit selection in RNAi high-throughput screens, J Biomol Screen, 16, 775, 10.1177/1087057111405851 Curtis, 2012, The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, 486, 346, 10.1038/nature10983 Tyner, 2018, Functional genomic landscape of acute myeloid leukaemia, Nature, 562, 526, 10.1038/s41586-018-0623-z Iyer, 2015, The landscape of long noncoding RNAs in the human transcriptome, Nat Genet, 47, 199, 10.1038/ng.3192 Teng, 2016, A benchmark for RNA-seq quantification pipelines, Genome Biol, 17, 74, 10.1186/s13059-016-0940-1 Chen, 2016, A uniform survey of allele-specific binding and expression over 1000-Genomes-Project individuals, Nat Commun, 7, 11101, 10.1038/ncomms11101 O'Leary, 2016, Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation, Nucleic Acids Res, 44, D733, 10.1093/nar/gkv1189 El-Brolosy, 2017, Genetic compensation: A phenomenon in search of mechanisms, PLoS Genet., 13, 10.1371/journal.pgen.1006780 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci USA, 102, 15545, 10.1073/pnas.0506580102 Meng, 2017, RNA interference-induced innate immunity, off-target effect, or immune adjuvant?, Front Immunol, 8, 331, 10.3389/fimmu.2017.00331 Zack, 2013, Pan-cancer patterns of somatic copy number alteration, Nat Genet, 45, 1134, 10.1038/ng.2760 Macintyre, 2018, Copy number signatures and mutational processes in ovarian carcinoma, Nat Genet, 50, 1262, 10.1038/s41588-018-0179-8 Nibourel, 2017, Copy-number analysis identified new prognostic marker in acute myeloid leukemia, Leukemia, 31, 555, 10.1038/leu.2016.265 Hieronymus, 2018, Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death, Elife, 7, e37294, 10.7554/eLife.37294 Paolella, 2017, Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability, Elife, 6, e23268, 10.7554/eLife.23268 Meyers, 2017, Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells, Nat Genet, 1779, 10.1038/ng.3984 Bacher, 2006, Implications of NRAS mutations in AML: a study of 2502 patients, Blood, 107, 3847, 10.1182/blood-2005-08-3522 Maiti, 2019, Phase ii trial of mek inhibitor binimetinib (MEK162) in RAS-mutant acute myeloid leukemia, Clin Lymphoma Myeloma Leuk, 19, 10.1016/j.clml.2018.12.009 Salmans, 2013, The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker, Breast Cancer Res BCR, 15, 204, 10.1186/bcr3408 Datlinger, 2017, Pooled CRISPR screening with single-cell transcriptome readout, Nat Methods, 14, 10.1038/nmeth.4177 Kok, 2015, Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish, Dev. Cell, 32, 97, 10.1016/j.devcel.2014.11.018 Young, 2009, The prion or the related Shadoo protein is required for early mouse embryogenesis, FEBS Lett, 583, 3296, 10.1016/j.febslet.2009.09.027